Eosinophilic esophagitis (eoe)

Dupilumab is Efficacious Regardless of Endoscopic Phenotype: Post Hoc Analysis of the LIBERTY EoE TREET Study

Dupilumab Maintained Histologic and Endoscopic Improvements During the Open-Label Extension Period of the EoE KIDS Study

Dupilumab in Pediatric EoE: Phase 3 KIDS Study Results

This poster presentation evaluates the efficacy of dupilumab in treating eosinophilic esophagitis (EoE) in patients weighing ≥15 kg at baseline from the Phase 3 KIDS study.

EoETaly Guidelines Part-2

EoETaly Guidelines Part-1

Adaptive Eating Behaviors in EoE

Pediatric EoE: Indicators for Early Diagnosis and Intervention

EoE Pathophysiology

Understanding Eosinophilic Esophagitis (EoE)

Measures of Disease Severity in Eosinophilic Esophagitis (EoE)

Importance of assessing key disease domains in EOE

EOE Pediatric - Unmasking the Hidden Symptoms